Maternal Folate and Vitamin B(12) Status and Neural Tube Defects in Northern Iran: a Case Control Study

Overview

Journal Iran J Pediatr

Publisher Brieflands

Specialty Pediatrics

Date 2012 Oct 12

PMID 23056699

Citations 6

Authors

Elahm Mobasheri

Abbasali Keshtkar

Mohammad-Jafar Golalipour

Affiliations

Soon will be listed here.

Abstract

Objective: This study was conducted to determine the serum level of folic acid and vitamin B12 in neural tube defects pregnancies (NTD) and healthy controls in Northern Iran.

Methods: This case-control study was performed on women with neural tube defects pregnancies and controls with unaffected pregnancies in Northern Iran during 2006. Twenty three pregnant women whose pregnancies were diagnosed as NTD by a second-trimester ultrasonographic examination were recruited as cases. The control group (n=23) consisted of women who were selected among socio-economic status (SES) matched women who had a normal targeted ultrasound during the second trimester with documented normal fet al outcome. Fetal NTD was suspected with targeted second-trimester ultrasound during the 16(th) week of gestation and confirmed with high maternal serum α-fetoprotein levels. Folate, vitamin B(12), homocysteine and alpha fetoprotein were evaluated after target ultrasonography.

Findings: Serum alpha fetoprotein level (mean±SD) in cases and controls was 120.2±64.1 and 50±33.5 iu/ml, respectively (P<0.05). The mean±SD folate in cases and controls was 8.4±4.2 versus 9.3±4.2 ng/ml, respectively. This difference was not significant. Folate deficiency was found in 30.4% of the cases and 13% of the controls (OR=2.9, 95%: 0.54-19.8). Vitamin B12 deficiency was found in 13% of cases and 17.7% of the controls (OR=0.7, 95%: 0.1-4.9).

Conclusion: This study showed that the probability of having a newborn with NTDs in maternal folate deficiency is three times higher than with normal folate in Northern Iran.

Citing Articles

Determinants of neural tube defects among women who gave birth in hospitals in Eastern Ethiopia: evidence from a matched case control study.

Berhane A, Belachew T BMC Womens Health. 2023; 23(1):662.

PMID: 38071290 PMC: 10710723. DOI: 10.1186/s12905-023-02796-0.

Cobalamin and folate status in women during early pregnancy in Bhaktapur, Nepal.

Schwinger C, Sharma S, Chandyo R, Hysing M, Kvestad I, Ulak M J Nutr Sci. 2021; 10:e57.

PMID: 34422259 PMC: 8358842. DOI: 10.1017/jns.2021.53.

Factors associated with congenital anomalies in Addis Ababa and the Amhara Region, Ethiopia: a case-control study.

Taye M, Afework M, Fantaye W, Diro E, Worku A BMC Pediatr. 2018; 18(1):142.

PMID: 29699508 PMC: 5921791. DOI: 10.1186/s12887-018-1096-9.

Risk factors associated with neural tube defects in infants referred to western Iranian obstetrical centers; 2013-2014.

Zaheri F, Ranaie F, Shahoei R, Hasheminasab L, Roshani D Electron Physician. 2017; 9(6):4636-4642.

PMID: 28848641 PMC: 5557146. DOI: 10.19082/4636.

Quantitative assessment of maternal biomarkers related to one-carbon metabolism and neural tube defects.

Tang K, Li Y, Wang H Sci Rep. 2015; 5:8510.

PMID: 25728980 PMC: 4345334. DOI: 10.1038/srep08510.

References

Harris M, Juriloff D . Mini-review: toward understanding mechanisms of genetic neural tube defects in mice. Teratology. 1999; 60(5):292-305. DOI: 10.1002/(SICI)1096-9926(199911)60:5<292::AID-TERA10>3.0.CO;2-6. View

Zhang T, Xin R, Gu X, Wang F, Pei L, Lin L . Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr. 2008; 12(5):680-6. DOI: 10.1017/S1368980008002735. View

Kirke P, Molloy A, Daly L, Burke H, Weir D, Scott J . Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993; 86(11):703-8. View

Yates J, Ferguson-Smith M, Shenkin A, White M, Clark B . Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects?. Clin Genet. 1987; 31(5):279-87. DOI: 10.1111/j.1399-0004.1987.tb02809.x. View

van Loon K, Besseghir K, Eshkol A . Neural tube defects after infertility treatment: a review. Fertil Steril. 1992; 58(5):875-84. DOI: 10.1016/s0015-0282(16)55428-4. View

Golalipour M, Mansourian A, Keshtkar A . Serum zinc levels in newborns with neural tube defects. Indian Pediatr. 2006; 43(9):809-12. View

Neuhouser M, Beresford S, Hickok D, MONSEN E . Absorption of dietary and supplemental folate in women with prior pregnancies with neural tube defects and controls. J Am Coll Nutr. 1998; 17(6):625-30. DOI: 10.1080/07315724.1998.10718812. View

Wald N, Hackshaw A, Stone R, Sourial N . Blood folic acid and vitamin B12 in relation to neural tube defects. Br J Obstet Gynaecol. 1996; 103(4):319-24. DOI: 10.1111/j.1471-0528.1996.tb09735.x. View

Velie E, Block G, Shaw G, Samuels S, Schaffer D, Kulldorff M . Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. Am J Epidemiol. 1999; 150(6):605-16. DOI: 10.1093/oxfordjournals.aje.a010059. View

10.

Economides D, Ferguson J, MacKenzie I, Darley J, Ware I, HOLMES-SIEDLE M . Folate and vitamin B12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects. Br J Obstet Gynaecol. 1992; 99(1):23-5. DOI: 10.1111/j.1471-0528.1992.tb14386.x. View

11.

Seller M . Risks in spina bifida. Dev Med Child Neurol. 1994; 36(11):1021-5. DOI: 10.1111/j.1469-8749.1994.tb11799.x. View

12.

Wright M . A case-control study of maternal nutrition and neural tube defects in Northern Ireland. Midwifery. 1995; 11(3):146-52. DOI: 10.1016/0266-6138(95)90029-2. View

13.

Botto L, Yang Q . 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000; 151(9):862-77. DOI: 10.1093/oxfordjournals.aje.a010290. View

14.

Schorah C, Smithells R, Scott J . Vitamin B12 and anencephaly. Lancet. 1980; 1(8173):880. DOI: 10.1016/s0140-6736(80)91381-1. View

15.

Shaw G, TODOROFF K, Schaffer D, Selvin S . Periconceptional nutrient intake and risk for neural tube defect-affected pregnancies. Epidemiology. 1999; 10(6):711-6. View

16.

Gaber K, Farag M, Soliman S, El-Bassyouni H, El-Kamah G . Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients. Clin Lab. 2007; 53(1-2):69-75. View

17.

Mills J, Tuomilehto J, Yu K, Colman N, Blaner W, Koskela P . Maternal vitamin levels during pregnancies producing infants with neural tube defects. J Pediatr. 1992; 120(6):863-71. DOI: 10.1016/s0022-3476(05)81951-1. View

18.

Suarez L, Hendricks K, Felkner M, Gunter E . Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol. 2003; 13(2):81-8. DOI: 10.1016/s1047-2797(02)00267-3. View

19.

Molloy A, Kirke P, Hillary I, Weir D, Scott J . Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects. Arch Dis Child. 1985; 60(7):660-5. PMC: 1777297. DOI: 10.1136/adc.60.7.660. View

20.

Thorand B, Pietrzik K, Prinz-Langenohl R, Hages M, Holzgreve W . Maternal and fetal serum and red blood cell folate and vitamin B12 concentrations in pregnancies affected by neural tube defects. Z Geburtshilfe Neonatol. 1996; 200(5):176-80. View